Renal Cell Cancer Treated with a Single-Edged Sword

Emerson Lim; Edward P. Gelmann

doi:10.1016/j.celrep.2013.02.001

Cell Reports (Feb 2013)

Renal Cell Cancer Treated with a Single-Edged Sword

Emerson Lim,
Edward P. Gelmann

Affiliations

Emerson Lim: Departments of Medicine and Pathology, Herbert Irving Comprehensive Cancer Center, Columbia University, 177 Fort Washington Avenue, MHB 6N-435, New York, NY 10032, USA
Edward P. Gelmann: Departments of Medicine and Pathology, Herbert Irving Comprehensive Cancer Center, Columbia University, 177 Fort Washington Avenue, MHB 6N-435, New York, NY 10032, USA

DOI: https://doi.org/10.1016/j.celrep.2013.02.001
Journal volume & issue: Vol. 3, no. 2
pp. 275 – 276

Abstract

Read online

Preclinical and early clinical data suggest that antiangiogenic treatments may lead to more aggressive tumors. In this issue of Cell Reports, Blagoev et al. (2013) show that sunitinib, a multikinase inhibitor with antiangiogenic effects, does not worsen the survival of patients with metastatic kidney cancer.

Published in Cell Reports

ISSN: 2211-1247 (Online)
Publisher: Elsevier
Country of publisher: Netherlands
LCC subjects: Science: Biology (General)
Website: http://www.cell.com/cell-reports/home

About the journal